Carroll Financial Associates’s Zai Lab ZLAB Stock Holding History

Carroll Financial Associates’s Portfolio ZLAB Stock Details ZLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2	Closed	–	–	1985
2021 Q3	$0	Buy	+2	New	+$287	﹤0.01%	1975

Other funds holding ZLAB

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BAM

Brilliance Asset Management Admiralty, Hong Kong, Hong Kong $339M AUM 9.81% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Carroll Financial Associates's ZLAB Position: Q4 2021 in Review

Carroll Financial Associates sold out of Zai Lab (ZLAB) in Q4 2021, closing a stake of 2 shares.

Carroll Financial Associates first reported a position in ZLAB in Q3 2021 and held it in 1 quarter. The position peaked at $0 in Q3 2021. 207 funds tracked by Wall St. Rank hold ZLAB as of Q4 2021.

Carroll Financial Associates reported no remaining Zai Lab position as of Q4 2021 after selling out during the quarter.
Carroll Financial Associates sold 2 Zai Lab shares in Q4 2021.
Carroll Financial Associates first reported a position in Zai Lab in Q3 2021 and held it in 1 quarter.
Carroll Financial Associates's Zai Lab position peaked at $0 in Q3 2021.
207 funds tracked by Wall St. Rank held Zai Lab as of Q4 2021.

Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.